Insider Transactions in Q3 2024 at Wave Life Sciences Ltd. (WVE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,791,930
+14.27%
|
$22,335,440
$8.0 P/Share
|
|
Sep 25
2024
|
Kyle Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,146
-46.44%
|
$154,314
$9.0 P/Share
|
|
Aug 21
2024
|
Paul Bolno President and CEO |
SELL
Open market or private sale
|
Direct |
48,366
-11.87%
|
$241,830
$5.78 P/Share
|
|
Aug 12
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
16,115
+50.0%
|
-
|
|
Aug 12
2024
|
Ken Takanashi |
BUY
Grant, award, or other acquisition
|
Direct |
16,115
+0.28%
|
-
|
|
Aug 12
2024
|
Heidi L Wagner |
BUY
Grant, award, or other acquisition
|
Direct |
32,230
+50.0%
|
-
|
|
Aug 12
2024
|
Gregory L. Verdine |
BUY
Grant, award, or other acquisition
|
Direct |
16,115
+25.9%
|
-
|
|
Aug 12
2024
|
Mark Corrigan |
BUY
Grant, award, or other acquisition
|
Direct |
32,230
+50.0%
|
-
|
|
Aug 12
2024
|
Christian O Henry |
BUY
Grant, award, or other acquisition
|
Direct |
16,115
+50.0%
|
-
|
|
Aug 12
2024
|
Aik Na Tan |
BUY
Grant, award, or other acquisition
|
Direct |
16,115
+50.0%
|
-
|
|
Aug 12
2024
|
Adrian Rawcliffe |
BUY
Grant, award, or other acquisition
|
Direct |
16,115
+50.0%
|
-
|
|
Jul 22
2024
|
Chandra Vargeese |
BUY
Exercise of conversion of derivative security
|
Direct |
68,210
+26.93%
|
$136,420
$2.48 P/Share
|